# FDA Inspection 1239760 - Regeneron Pharmaceuticals Inc - February 16, 2024

Source: https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/be92bc21-d599-4a82-9b9d-dde944acebd3
Source feed: FDA_Inspections

> FDA Inspection 1239760 for Regeneron Pharmaceuticals Inc on February 16, 2024. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1239760
- Company Name: Regeneron Pharmaceuticals Inc
- Inspection Date: 2024-02-16
- Product Type: Human Drugs
- Office Name: New York District Office

## Related Documents

- [FDA Inspection 1230565 - 2024-03-22](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/7df63927-1928-4995-8887-1541aa1d5420)
- [FDA Inspection 1155063 - 2021-10-25](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/f2f814f1-cd34-4b8c-9b74-fb3e6156fa2d)
- [FDA Inspection 1106821 - 2019-10-18](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/2d3aca16-4c83-4b48-914c-5f89d3ad6cde)
- [FDA Inspection 1030807 - 2017-10-05](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/9fbb9269-f14d-4a71-a17c-ebb14c24aed4)
- [FDA Inspection 983604 - 2016-08-19](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/caf7d10a-59bc-40a1-b6f6-8e3e13e51b49)

Company: https://www.keypedia.com/companies/regeneron-pharmaceuticals-inc/cd765cfa-95e6-4023-ade2-0ffa382fe2c7

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d